Yuen Maggie, AtriCure executive, sold 3,500 shares at $38.42 each, totaling $134,470. The transaction was reported to the SEC within two business days of the trade.
Yuen Maggie, an executive at AtriCure, sold 3,500 shares of the company at $38.42 each, totaling $134,470, according to data filed with the SEC.
Who is Yuen Maggie and What is Her Real Role at AtriCure
Yuen Maggie is an executive at AtriCure, Inc., a company specializing in the development and commercialization of solutions for treating cardiac arrhythmias. As an executive, Yuen Maggie has access to privileged information about the company, including its financial performance, strategies, and development plans. This role gives her a deep understanding of the company and enables her to make informed decisions regarding her personal investments.
Company executives like Yuen Maggie often have intimate knowledge of the company's operations and performance. They are also involved in strategic decision-making that can impact the value of the company's shares. This means that transactions made by these executives can be considered potential indicators of their confidence in the company and its future prospects.
However, it is important to note that executives may buy or sell shares for various reasons, including personal ones, and that these transactions do not necessarily reflect their opinions on the company's prospects. Investors should always conduct their own research and consider multiple information sources before making investment decisions.
Transaction Details: 3,500 shares at $38.42 each
The transaction carried out by Yuen Maggie involves the sale of 3,500 AtriCure shares at a per-share price of $38.42. The total value of the transaction amounts to $134,470. It is crucial to distinguish between the per-share price and the total transaction value, as these are two distinct figures that provide different insights into the transaction.
The per-share price, in this case $38.42, indicates the amount paid for each share sold. The total transaction value, on the other hand, represents the total amount received by Yuen Maggie for the sale of all shares, totaling $134,470. This distinction is essential for understanding the scope of the transaction and its potential impact on the insider's portfolio.
Why Insiders Sell Their Shares â Possible Reasons
Insiders like Yuen Maggie may sell their shares for a variety of reasons. One common reason is portfolio diversification. Executives may wish to spread their investments to minimize risks and maximize returns. The sale of shares may also be motivated by tax considerations, such as planning for capital gains taxes or managing losses.
Another possible reason is the need for liquidity. Insiders may have expenses or commitments that require liquid funds, and the sale of shares may represent a way to generate these funds. However, it is important to consider that insider transactions, whether purchases or sales, should not be interpreted as investment signals for individual investors.
Insider transactions may also be considered as confidence indicators in the company. However, it is crucial to nuance these interpretations by considering the potential reasons behind these transactions. Individual investors should remember that insiders may sell for reasons unrelated to performance or prospects.
